Vai al contenuto principale della pagina

Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Tagit Oya Visualizza persona
Titolo: Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside Visualizza cluster
Pubblicazione: Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica: 1 online resource (296 p.)
Soggetto topico: History of engineering and technology
Materials science
Technology: general issues
Soggetto non controllato: 3D culture
amine
angiotensin
animal model
anti-inflammatory
antigen release
atorvastatin calcium
biocompatible
biodegradable
blood-brain barrier (BBB)
brightness
cancer
cardiovascular
carrageenan induced inflammation
central nervous system
chemoimmunotherapy
chitosan
clinical translation
confocal microscopy
coumarin 6
current Good Manufacturing Practice (cGMP)
Cy5.5
cytotoxicity
design of experiments
DiI
double emulsion solvent evaporation
double-emulsion method
downstream processing
drug delivery
drug delivery system
drug release
drug release kinetics modeling
dry powder inhalation
emulsion
encapsulation
ester and acid-end capped
fluorescent labeling
Food and Drug Administration (FDA)
H. pylori
immune checkpoint blockade
immunogenic cell death
in vitro
in vivo neuroimaging
Indomethacin
inline sonication
intracellular internalization
JO-4
Katushka
lyophilization
mas receptor
methotrexate
micro-implant
microfluidic
microfluidics
minimally invasive
morphology
nanomedicine
nanoparticle
nanoparticles
nanotechnology
neurodegenerative diseases
neuroprotective drugs
nuclear medicine
orthotopic tumors
particle-size
PEGylation
pharmacokinetics (PK) and biodistribution
photothermal therapy
phthalocyanine
PLA/PLGA
PLGA
PLGA diblock copolymer
PLGA nanoparticles
Pluronic triblock copolymer
PNA5 glycopeptide
poly (lactic-co-glycolic acid) (PLGA)
poly(lactic-co-glycolic acid)
poly(lactic-co-glycolic acid) (PLGA)
poly(lactic-co-glycolic) acid
poly(lactide-co-glycolide)
polymeric nanoparticles
polyvinyl alcohol (PVA)
porous PLGA particles
quantum yield
radiolabeled nanoparticles
rhodamine 123
scale-up manufacturing
size
SKOVip-kat
solid-state characterization
solvents
spheroids
stability of fluorescent label
stabilizers
sucrose
sustained release
tangential flow filtration
trehalose
TurboFP635
Persona (resp. second.): TagitOya
Sommario/riassunto: Nanomedicine is among the most promising emerging fields that can provide innovative and radical solutions to unmet needs in pharmaceutical formulation development. Encapsulation of active pharmaceutical ingredients within nano-size carriers offers several benefits, namely, protection of the therapeutic agents from degradation, their increased solubility and bioavailability, improved pharmacokinetics, reduced toxicity, enhanced therapeutic efficacy, decreased drug immunogenicity, targeted delivery, and simultaneous imaging and treatment options with a single system.Poly(lactide-co-glycolide) (PLGA) is one of the most commonly used polymers in nanomedicine formulations due to its excellent biocompatibility, tunable degradation characteristics, and high versatility. Furthermore, PLGA is approved by the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) for use in pharmaceutical products. Nanomedicines based on PLGA nanoparticles can offer tremendous opportunities in the diagnosis, monitoring, and treatment of various diseases.This Special Issue aims to focus on the bench-to-bedside development of PLGA nanoparticles including (but not limited to) design, development, physicochemical characterization, scale-up production, efficacy and safety assessment, and biodistribution studies of these nanomedicine formulations.
Altri titoli varianti: Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease
Titolo autorizzato: Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910580215803321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui